Found: 18
Select item for more details and to access through your institution.
Nanoscale nuclear architecture for cancer diagnosis beyond pathology via spatial-domain low-coherence quantitative phase microscopy.
- Published in:
- Journal of Biomedical Optics, 2010, v. 15, n. 6, p. 066028, doi. 10.1117/1.3523618
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
Pharmacokinetic assessment of <sup>18</sup>F-(2S,4R)-4-fluoroglutamine in patients with cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.229740
- By:
- Publication type:
- Article
Assessment of simplified methods for quantification of 18F-FDHT uptake in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.220111
- By:
- Publication type:
- Article
Assessment of Simplified Methods for Quantification of <sup>18</sup>F-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 9, p. 1221, doi. 10.2967/jnumed.118.220111
- By:
- Publication type:
- Article
Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 10, p. 1516, doi. 10.2967/jnumed.117.206490
- By:
- Publication type:
- Article
Biodistribution and Dosimetry of <sup>18</sup>F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 1, p. 147, doi. 10.2967/jnumed.117.193169
- By:
- Publication type:
- Article
Pharmacokinetic Analysis of Dynamic <sup>18</sup>F-Fluoromisonidazole PET Data in Non--Small Cell Lung Cancer.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 6, p. 911, doi. 10.2967/jnumed.116.180422
- By:
- Publication type:
- Article
Assessment of Nuclear Nanomorphology Marker to Improve the Detection of Malignancy From Bile Duct Biopsy Specimens.
- Published in:
- American Journal of Clinical Pathology, 2014, v. 141, n. 6, p. 884, doi. 10.1309/AJCPXQD0NSJNK0CX
- By:
- Publication type:
- Article
Preclinical Evaluation of <sup>89</sup>Zr-Df-IAB22M2C PET as an Imaging Biomarker for the Development of the GUCY2C-CD3 Bispecific PF-07062119 as a T Cell Engaging Therapy.
- Published in:
- Molecular Imaging & Biology, 2021, v. 23, n. 6, p. 941, doi. 10.1007/s11307-021-01621-0
- By:
- Publication type:
- Article